|
[1]
|
Nanotechnology Applications for the Diagnosis and Therapeutic Treatment of Fungal Diseases
2026
DOI:10.1016/B978-0-443-29273-6.00002-3
|
|
|
|
|
[2]
|
Interconnected worlds: a comprehensive review of fungal defenses, antimicrobial resistance, and their evolutionary dynamics
IMA Fungus,
2026
DOI:10.3897/imafungus.17.171995
|
|
|
|
|
[3]
|
Sustained Release Bifonazole Film Forming Spray for Effective Fungal Treatment
Journal of Pharmaceutical Innovation,
2026
DOI:10.1007/s12247-026-10378-4
|
|
|
|
|
[4]
|
Structural barriers to antifungal drug development
Frontiers in Cellular and Infection Microbiology,
2026
DOI:10.3389/fcimb.2026.1797104
|
|
|
|
|
[5]
|
Smart Antifungal Therapy: Lipase-Responsive Ketoconazole and Atorvastatin Co-loaded Poly є-caprolactone Nanoparticles for Cutaneous Candidiasis
AAPS PharmSciTech,
2025
DOI:10.1208/s12249-025-03253-x
|
|
|
|
|
[6]
|
Antibiofilm sustainable strategies: pomegranate extract from agri-food waste as a natural antifungal against emerging Candida pathogens
Frontiers in Microbiology,
2025
DOI:10.3389/fmicb.2025.1724685
|
|
|
|
|
[7]
|
Unravelling azole resistance in fungal pathogens: molecular mechanisms, diagnostic challenges, and therapeutic strategies
World Journal of Microbiology and Biotechnology,
2025
DOI:10.1007/s11274-025-04671-6
|
|
|
|
|
[8]
|
Environmental microbiome, human fungal pathogens, and antimicrobial resistance
Trends in Microbiology,
2025
DOI:10.1016/j.tim.2024.08.003
|
|
|
|
|
[9]
|
Fabrication of chitosan-coated ciprofloxacin drug nanocomposite for combating antibacterial and respiratory infection leading to sepsis
Journal of Materials Research,
2025
DOI:10.1557/s43578-024-01507-1
|
|
|
|
|
[10]
|
The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Chemical Biology & Drug Design,
2025
DOI:10.1111/cbdd.70045
|
|
|
|
|
[11]
|
Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems
Materials,
2025
DOI:10.3390/ma18071580
|
|
|
|
|
[12]
|
Targeting biofilm formation in Candida albicans with halogenated pyrrolopyrimidine derivatives
European Journal of Medicinal Chemistry,
2025
DOI:10.1016/j.ejmech.2025.117528
|
|
|
|
|
[13]
|
AI in fungal drug development: opportunities, challenges, and future outlook
Frontiers in Cellular and Infection Microbiology,
2025
DOI:10.3389/fcimb.2025.1610743
|
|
|
|
|
[14]
|
Identification, quantification, and bioactivity of Vitex negundo phenolic acids as efficacious anti-candidal and antibiofilm agents targeting Candida albicans
Journal of Medical Mycology,
2025
DOI:10.1016/j.mycmed.2025.101550
|
|
|
|
|
[15]
|
The exploring AI-generated pyrazalone derivatives as antifungal agents: Bringing together molecular docking and quantum chemical approaches
Computational Biology and Chemistry,
2025
DOI:10.1016/j.compbiolchem.2025.108502
|
|
|
|
|
[16]
|
Advancements in microfluidic-based synthesis of niosomes for cancer and infection therapy: A comprehensive review
Journal of Molecular Liquids,
2025
DOI:10.1016/j.molliq.2025.128048
|
|
|
|
|
[17]
|
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives
Infectious Disease Reports,
2025
DOI:10.3390/idr17040091
|
|
|
|
|
[18]
|
Antifungal and Immunomodulatory Activities of Brazilian Savannah Solanum lypocarpum Tree-Associated Streptomyces Isolates
Pharmaceuticals,
2025
DOI:10.3390/ph18081158
|
|
|
|
|
[19]
|
Releases of inhibition mechanisms and binding of antifungal compounds against validated proteins for drug design post-WHO priority list: A review
International Journal of Biological Macromolecules,
2025
DOI:10.1016/j.ijbiomac.2025.146139
|
|
|
|
|
[20]
|
Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin
International Journal of Molecular Sciences,
2025
DOI:10.3390/ijms26167909
|
|
|
|
|
[21]
|
Integrating Artificial Intelligence in Combatting Fungal Diseases: Diagnosis, Antifungal Resistance, and Therapeutic Strategies
2025 International Conference on Machine Intelligence and Smart Innovation (ICMISI),
2025
DOI:10.1109/ICMISI65108.2025.11115246
|
|
|
|
|
[22]
|
Prevalence of Fungal Keratitis in Suspected Keratomycosis Cases Over Five Years in Southeastern Iran
Archives of Clinical Infectious Diseases,
2025
DOI:10.5812/archcid-161256
|
|
|
|
|
[23]
|
Multidrug-resistant yeasts in fresh fruits from organic and conventional farming: quantification, species identification, and antifungal susceptibility profiles
Letters in Applied Microbiology,
2025
DOI:10.1093/lambio/ovaf116
|
|
|
|
|
[24]
|
Candida Susceptibility to Antifungals in Amniotic Fluid: A Preliminary Study
Pathogens,
2025
DOI:10.3390/pathogens14100972
|
|
|
|
|
[25]
|
A Pragmatic Strategy for Improving Diagnosis of Invasive Candidiasis in UK and Ireland ICUs
Journal of Fungi,
2025
DOI:10.3390/jof11110784
|
|
|
|
|
[26]
|
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains
Scientific Reports,
2025
DOI:10.1038/s41598-025-26841-0
|
|
|
|
|
[27]
|
Biomimetic Antifungal Materials: Countering the Challenge of Multidrug-Resistant Fungi
Biomimetics,
2024
DOI:10.3390/biomimetics9070425
|
|
|
|